All In MedTech

FDA Clearance Tracker · P930016-S057

STAR S4 IR Excimer Laser System and iDESIGN Refractive Studio

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 9, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 9, 2019

Approved

Time to decision

250 days

Received Jan 2, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P930016-S057
Device name
STAR S4 IR Excimer Laser System and iDESIGN Refractive Studio
Applicant location
Milpitas, CA
Received
Jan 2, 2019
Decided
Sep 9, 2019
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P930016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

Approval for the STAR S4 IR® Excimer Laser System and iDESIGN® Refractive Studio. This device is indicated for wavefront-guided photorefractive keratectomy (PRK) in patients:1) with myopia, with or without astigmatism, as measured by iDESIGN® Refractive Studio System with spherical equivalent up to -8.00 D, and cylinder up to -3.00 D. 2) with agreement between manifest refraction (adjusted for optical infinity) and iDESIGN® Refractive Studio System refraction as follows: a) Spherical Equivalent: Magnitude of the difference is less than 0.625 D. b) Cylinder: Magnitude of the difference is less than or equal to 0.5 D. 3) in patients 18 years of age or older.4) with refractive stability (a change of </= 1.0 D in manifest refraction spherical equivalent for a minimum of 12 months prior to surgery), and5) with wavefront capture diameter of at least 4 mm.

Source documents

Other decisions for Amo Manufacturing USA, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.